Laurent Fischer is the founder of Adverum Biotechnologies. Adverum Biotechnologies has raised $55M in total funding. Latest round: Series B.
Laurent Fischer took over as CEO of Adverum Biotechnologies in 2020. Adverum Biotechnologies is a clinical-stage gene therapy company based in Redwood City, California, that develops single-administration treatments for severe ocular and other rare diseases. The company has secured significant capital across multiple financing rounds, including a $102 million initial public offering and a $127 million private placement in early 2024, and had a $55M Series B in April 2014.
Full founder directory · Investor directory · Company funding database · Fundraising library